Compare VFS & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VFS | HIMS |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | Vietnam | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 8.9B |
| IPO Year | N/A | N/A |
| Metric | VFS | HIMS |
|---|---|---|
| Price | $3.43 | $34.17 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 12 |
| Target Price | $5.83 | ★ $44.90 |
| AVG Volume (30 Days) | 382.4K | ★ 11.7M |
| Earning Date | 11-21-2025 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.76 |
| EPS | N/A | ★ 0.54 |
| Revenue | ★ $2,554,394,588.00 | $2,210,958,000.00 |
| Revenue This Year | $93.79 | $62.27 |
| Revenue Next Year | $54.02 | $18.20 |
| P/E Ratio | ★ N/A | $66.05 |
| Revenue Growth | ★ 81.20 | 78.02 |
| 52 Week Low | $2.56 | $23.97 |
| 52 Week High | $4.50 | $72.98 |
| Indicator | VFS | HIMS |
|---|---|---|
| Relative Strength Index (RSI) | 53.02 | 41.84 |
| Support Level | $3.30 | $32.05 |
| Resistance Level | $3.60 | $36.45 |
| Average True Range (ATR) | 0.09 | 1.41 |
| MACD | 0.00 | 0.26 |
| Stochastic Oscillator | 46.23 | 44.77 |
VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.